These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

872 related articles for article (PubMed ID: 22807098)

  • 101. Does renal artery supply indicate treatment success of renal denervation?
    Schmid A; Ditting T; Sobotka PA; Veelken R; Schmieder RE; Uder M; Ott C
    Cardiovasc Intervent Radiol; 2013 Aug; 36(4):987-91. PubMed ID: 23771326
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Effects of Renal Sympathetic Denervation on Arterial Stiffness and Blood Pressure Control in Resistant Hypertensive Patients: A Single Centre Prospective Study.
    Baroni M; Nava S; Giupponi L; Meani P; Panzeri F; Varrenti M; Maloberti A; Soriano F; Agrati AM; Ferraro G; Colombo F; Rampoldi A; Mancia G; Colombo P; Klugmann S; Giannattasio C
    High Blood Press Cardiovasc Prev; 2015 Dec; 22(4):411-6. PubMed ID: 26458940
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Long-term effects of multielectrode renal denervation on cardiac adaptations in resistant hypertensive patients with left ventricular hypertrophy.
    Tsioufis C; Papademetriou V; Dimitriadis K; Kasiakogias A; Kordalis A; Andrikou E; Milkas A; Liatakis I; Lau EO; Tousoulis D
    J Hum Hypertens; 2016 Nov; 30(11):714-719. PubMed ID: 26818805
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Expanding the indication spectrum: renal denervation in diabetes.
    Mahfoud F; Ewen S; Ukena C; Linz D; Sobotka PA; Cremers B; Böhm M
    EuroIntervention; 2013 May; 9 Suppl R():R117-21. PubMed ID: 23732142
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Alcohol-Mediated Renal Denervation Using the Peregrine System Infusion Catheter for Treatment of Hypertension.
    Mahfoud F; Renkin J; Sievert H; Bertog S; Ewen S; Böhm M; Lengelé JP; Wojakowski W; Schmieder R; van der Giet M; Parise H; Haratani N; Pathak A; Persu A
    JACC Cardiovasc Interv; 2020 Feb; 13(4):471-484. PubMed ID: 32081241
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Long-term follow-up of patients undergoing renal sympathetic denervation.
    Zeijen VJM; Feyz L; Nannan Panday R; Veen K; Versmissen J; Kardys I; Van Mieghem NM; Daemen J
    Clin Res Cardiol; 2022 Nov; 111(11):1256-1268. PubMed ID: 35851428
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Role of Adding Spironolactone and Renal Denervation in True Resistant Hypertension: One-Year Outcomes of Randomized PRAGUE-15 Study.
    Rosa J; Widimský P; Waldauf P; Lambert L; Zelinka T; Táborský M; Branny M; Toušek P; Petrák O; Čurila K; Bednář F; Holaj R; Štrauch B; Václavík J; Nykl I; Krátká Z; Kociánová E; Jiravský O; Rappová G; Indra T; Widimský J
    Hypertension; 2016 Feb; 67(2):397-403. PubMed ID: 26693818
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Endovascular treatment of resistant and uncontrolled hypertension: therapies on the horizon.
    Bunte MC; Infante de Oliveira E; Shishehbor MH
    JACC Cardiovasc Interv; 2013 Jan; 6(1):1-9. PubMed ID: 23266234
    [TBL] [Abstract][Full Text] [Related]  

  • 109. [Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].
    Mahfoud F; Vonend O; Bruck H; Clasen W; Eckert S; Frye B; Haller H; Hausberg M; Hoppe UC; Hoyer J; Hahn K; Keller T; Krämer BK; Kreutz R; Potthoff SA; Reinecke H; Schmieder R; Schwenger V; Kintscher U; Böhm M; Rump LC;
    Dtsch Med Wochenschr; 2011 Nov; 136(47):2418. PubMed ID: 22048949
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Possibility of evaluating the effectiveness of renal artery sympathetic denervation in resistant hypertension early after radiofrequency ablation].
    Rebrova TY; Ripp TM; Afanasiev SA; Mordovin VF; Muslimova EF
    Ter Arkh; 2016; 88(8):10-13. PubMed ID: 27636920
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Renal Sympathetic Denervation by CT-Guided Ethanol Injection: A Phase II Pilot Trial of a Novel Technique.
    Ricke J; Seidensticker M; Becker S; Schiefer J; Adamchic I; Lohfink K; Kandulski M; Heller A; Mertens PR
    Cardiovasc Intervent Radiol; 2016 Feb; 39(2):251-60. PubMed ID: 26634740
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Renal Denervation in Patients With Uncontrolled Hypertension and Confirmed Adherence to Antihypertensive Medications.
    Hameed MA; Pucci M; Martin U; Watkin R; Doshi S; Freedman J; Riley P; Townend J; Crowe P; Lipkin G; Dasgupta I
    J Clin Hypertens (Greenwich); 2016 Jun; 18(6):565-71. PubMed ID: 26434739
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    Ewen S; Dörr O; Ukena C; Linz D; Cremers B; Laufs U; Hamm C; Nef H; Bauer A; Mancia G; Böhm M; Mahfoud F
    J Hypertens; 2015 Dec; 33(12):2512-8. PubMed ID: 26485461
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.
    Bakris GL; Townsend RR; Liu M; Cohen SA; D'Agostino R; Flack JM; Kandzari DE; Katzen BT; Leon MB; Mauri L; Negoita M; O'Neill WW; Oparil S; Rocha-Singh K; Bhatt DL;
    J Am Coll Cardiol; 2014 Sep; 64(11):1071-8. PubMed ID: 24858423
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Mahfoud F; Urban D; Teller D; Linz D; Stawowy P; Hassel JH; Fries P; Dreysse S; Wellnhofer E; Schneider G; Buecker A; Schneeweis C; Doltra A; Schlaich MP; Esler MD; Fleck E; Böhm M; Kelle S
    Eur Heart J; 2014 Sep; 35(33):2224-31b. PubMed ID: 24603307
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Vascular and renal hemodynamic changes after renal denervation.
    Ott C; Janka R; Schmid A; Titze S; Ditting T; Sobotka PA; Veelken R; Uder M; Schmieder RE
    Clin J Am Soc Nephrol; 2013 Jul; 8(7):1195-201. PubMed ID: 23559677
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Pathophysiology of renal denervation procedures: from renal nerve anatomy to procedural parameters.
    Ammar S; Ladich E; Steigerwald K; Deisenhofer I; Joner M
    EuroIntervention; 2013 May; 9 Suppl R():R89-95. PubMed ID: 23732162
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.
    Worthley SG; Tsioufis CP; Worthley MI; Sinhal A; Chew DP; Meredith IT; Malaiapan Y; Papademetriou V
    Eur Heart J; 2013 Jul; 34(28):2132-40. PubMed ID: 23782649
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting.
    McAdam-Marx C; Ye X; Sung JC; Brixner DI; Kahler KH
    Clin Ther; 2009 May; 31(5):1116-23. PubMed ID: 19539112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.